Transplacental chemical carcinogenesis in man.
D000014:Abnormalities, Drug-Induced; D000630:Aminopterin / Q000009:adverse effects; D000818:Animals; D002701:Chloramphenicol / Q000009:adverse effects; D004054:Diethylstilbestrol / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008431:Maternal-Fetal Exchange; D008727:Methotrexate / Q000009:adverse effects; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced*; D009379:Neoplasms, Muscle Tissue / Q000139:chemically induced; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014625:Vaginal Neoplasms / Q000139:chemically induced*
D007166:Immunosuppressive Agents; D010672:Phenytoin; D002701:Chloramphenicol; D004054:Diethylstilbestrol; D000630:Aminopterin; D008727:Methotrexate